Cleared Traditional

K981197 - ONE STEP URINE DRUG OF ABUSE AMPHETAMINE TEST

K981197 is an FDA 510(k) clearance for ONE STEP URINE DRUG OF ABUSE AMPHETAMIN..., manufactured by Tcpi, Inc.. The device is a Class 2 Toxicology device with product code DKZ cleared through the Traditional 510(k) pathway after a 75-day FDA review.

K981197 · Tcpi, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
75d
Days
Class 2
Risk

K981197 is an FDA 510(k) clearance for the ONE STEP URINE DRUG OF ABUSE AMPHETAMINE TEST. Classified as Enzyme Immunoassay, Amphetamine (product code DKZ), Class II - Special Controls.

Submitted by Tcpi, Inc. (Ft. Lauderdale, US). The FDA issued a Cleared decision on June 16, 1998 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3100 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tcpi, Inc. devices

FDA 510(k) Submission Details - K981197

510(k) Number K981197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 1998
Decision Date June 16, 1998
Days to Decision 75 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 87d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DKZ Device Classification - Class 2, Special Controls

Product Code DKZ Enzyme Immunoassay, Amphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DKZ Enzyme Immunoassay, Amphetamine

All 186
Devices cleared under the same product code (DKZ) and FDA review panel - the closest regulatory comparables to K981197.
MODIFICATION TO ABUSCREEN ONLINE FOR AMPHETAMINES
K983699 · Roche Diagnostic Systems, Inc. · Dec 1998
'RAPID DRUG SCREEN' 8 PANEL-LOW VOLUME
K981705 · American Bio Medica Corp. · Aug 1998
DBEST AMPHETAMINES TEST KIT
K981504 · Ameritek, Inc. · Aug 1998
QUICKSCREEN PRO MULTI DRUG SCREENING TEST , MODEL 9140-9147, 9061,9066, 9071, 9076, 9081 AND 9131
K980865 · Phamatech · Apr 1998
MICRO-STRIP FOR AMPHETAMINE METABOLITES
K974611 · Microdiagnostics, Inc. · Mar 1998
STC METHAMPHETAMINE MICRO-PLATE EIA
K972989 · OraSure Technologies, Inc. · Jan 1998